SLC13A2 and chronic kidney disease: In CKD, declining GFR impairs SLC26A1-mediated oxalate secretion, increasing urinary oxalate, while acidosis disrupts SLC13A2/SLC13A3 (NaDC-1/NaDC-3), reducing citrate levels and favoring lithogenesis [72,87].